Hepatitis C virus treatment as prevention among injecting drug users: who should we cure first?
Treatment of injecting drug users (IDU) for hepatitis C virus (HCV) infection may prevent onward transmission. Treating individuals who often share injecting equipment is most likely to prevent new infections. However, these high‐risk IDU are also more likely to become re‐infected than low‐risk IDU. We investigated to which group treatment is best targeted.
No Supplementary Data
No Article Media